Pharmacology of balance and dizziness

被引:15
作者
Lin, Emerald [1 ]
Aligene, Kathy [2 ]
机构
[1] Kessler Inst Rehabil, W Orange, NJ 07052 USA
[2] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA
关键词
Dizziness; vertigo; orthostatic hypotension; ototoxicity; SEROTONIN REUPTAKE INHIBITORS; MOTION SICKNESS; CALCIUM-ANTAGONISTS; MENIERES-DISEASE; DOUBLE-BLIND; INDUCED OTOTOXICITY; MEDICAL-TREATMENT; CONTROLLED TRIAL; VERTIGO; MIGRAINE;
D O I
10.3233/NRE-130875
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTION: Dizziness and vertigo encompass a spectrum of balance-related symptoms caused by a variety of etiologies. Balance is affected by many systems: proprioceptive pathways, and visual, cerebellar, vestibulocochlear, and vascular/vasovagal systems. Treatment includes antihistamines, antiemetics, benzodiazepines, anti-inflammatory, anti-Meniere's, anti-migraine, antidepressants, anticonvulsants, and aminopyridines. Many medications may cause these balance-related symptoms. Onset characteristics differ and may be reversible or irreversible. Ototoxic drugs may affect the cochlea, the vestibular system, or both. Medications, whether at "therapeutic" or toxic doses, have a spectrum of side effects, depending on the medication and individual. PURPOSE: The section on drugs that treat dizziness and balance deficiencies was divided to elaborate on medications by classes and etiology specific treatment. Drugs with potential to cause balance-related symptoms were chosen to elaborate on specific medical issues encountered in rehabilitation. Background on advantages of certain drugs and methods to minimize adverse effects are reviewed. SUMMARY: Effective treatment depends on generating an accurate diagnosis, using the appropriate drug, appropriate dosage, and for an appropriate duration. For every medication, there is a spectrum of side effects at "therapeutic" and toxic doses, depending on the medication and individual. CONCLUSION: Practitioners must ensure correct diagnoses and cater their treatments to the patients' clinical scenario and medical units' capacities.
引用
收藏
页码:529 / 542
页数:14
相关论文
共 102 条
[1]  
AFZELIUS LE, 1980, LARYNGOSCOPE, V90, P649
[2]  
[Anonymous], 2012, LOR DRUG INF
[3]  
[Anonymous], 2012, OND DRUG INF
[4]  
[Anonymous], 2012, DIM DRUG INF
[5]  
[Anonymous], 2012, MET DRUG INF
[6]  
[Anonymous], CLON DRUG INF
[7]  
[Anonymous], 2012, DIAZ DRUG INF
[8]  
[Anonymous], 2012, LID DRUG INF
[9]  
[Anonymous], 2012, MECL DRUG INF
[10]  
[Anonymous], 2012, DIPH SYST DRUG INF